DexCom (DXCM) Tops Q4 EPS by 37c

DexCom (NASDAQ: DXCM) reported Q4 EPS of $0.54, $0.37 better than the analyst estimate of $0.17. Revenue for the quarter came in at $338 million versus the consensus estimate of $307.52 million.

GUIDANCE:

DexCom sees FY2019 revenue of $1.175-1.225 billion, versus the consensus of $1.28 billion.

For earnings history and earnings-related data on DexCom (DXCM) click here.

You May Also Be Interested In

• Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• RCM Technologies (RCMT) Tops Q2 EPS by 17c